NONPROFIT, NONPARTISAN PLATFORM OF ACCURATE SCIENCE-BASED SOLUTIONS TO COVID-19

Intrasense

Business Name:
Intrasense
Business Genre:
Business Description:

They design solutions for advanced visualization and universal 3D imaging processing to accelerate medical image interpretation [1]

Country:
France
Data/Evidence of Effectiveness:
N/A
Complimentary Products Needed to Perform Test:
Need the Myrian image layer [3]
Setting of Care:
Should be in the clinical lab setting
Current Status / Clinical Development Stage / Expected Milestones:
Not FDA cleared/approved; FDA approved to meet EUA criteria [2]. Under EUA, cGMP requirements have been waived [2]; for in vitro diagnosis of SARS-CoV-2 infection [2].
Funding & Ownership :
Public [4], Cap 17.785 M [5]
Business Model:
They sell Myrain, the software solution for advanced visualization and analysis of multimodality medical images [1]
IP:
Certificate with ISO 13485 [1]
History & Origins :
Found in 2004. Combined skills in IT, math, engineer, and healthcare in solution for medical imging [1]
Date EUA Issued:
Myrian has been FDA cleared in 2007 [1]
Sources:
“[1] http://www.intrasense.fr/company/#our-mission [2] http://www.intrasense.fr/myrian-covid-19-protocol/ [3] http://www.intrasense.fr/myrian-imaging-layer/ [4] https://www.crunchbase.com/organization/intrasense-sa#section-overview [5] https://finance.yahoo.com/quote/ALINS.PA?p=ALINS.PA&.tsrc=fin-srch [6] https://www.linkedin.com/in/nicolasreymond/?originalSubdomain=fr”
Organization:
Nicolas Reymond (CEO) [6]
Time to Result:
N/A
Test Sample Type:
CT, radiology scan [2]
Technology Overview:
Based on the Myrain XP-Lung, lung range automatic segementation tool. Provide an measure of lung impairment and reserve in patients automatically and intuitively [2]
Testing Type:
radiology visualization, CT scan [2]
Test Category:
Other
Test Name:
Myrian Covid-19
Clinical Application & Need:
acute infection
Age of Company:
2004

Send Message to listing owner

Leave A Reply